Balaxi Pharma Fact Sheet, Balaxi Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Balaxi Pharma Fact Sheet    (BLPH)


Revealed: How Fund Managers Spot Winning Stocks


Here is the latest financial fact sheet of Balaxi Pharma. For more details, see the Balaxi Pharma quarterly results and Balaxi Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

BALAXI PHARMA Price History

Price Rs 619.0
Mkt Cap Rs m 6,190
Vol '000 6.5
P/E X 15.4
P/CF X 101.3
EPS (TTM) Rs 40.2
% ch % -2.8
No. of shares m 10.00
% ch week % 2.2
% ch 1-mth % 4.7
% ch 12-mth % 252.8
52 week H/L Rs 1,080.2/184.2
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BALAXI PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BALAXI PHARMA EQUITY SHARE DATA
High RsNANANANANA 
Low RsNANANANANA 
Sales per share (Unadj.) Rs0.20044.745.6 
Earnings per share (Unadj.) Rs-0.3-0.6-2.56.56.1 
Diluted earnings per shareRs-0.1-0.2-0.82.06.1 
Cash flow per share (Unadj.) Rs-0.3-0.6-2.56.56.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %NMNMNMNMNM 
Book value per share (Unadj.) Rs10.47.65.111.627.7 
Adj. book value per shareRs3.12.31.63.527.7 
Shares outstanding (eoy) m3.043.043.043.0410.00 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0NMNM00 
Avg P/E ratio x00000 
P/CF ratio (eoy) x00000 
Price / Book Value ratio x00000 
Dividend payout %00000 
Avg Mkt Cap Rs m00000 
No. of employees `000NANANANANA 
Total wages/salary Rs m112921 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BALAXI PHARMA INCOME DATA
Net Sales Rs m000136456 
Other income Rs m000928 
Total revenues Rs m000145484 
Gross profit Rs m-1-1-81661 
Depreciation Rs m00000 
Interest Rs m00000 
Profit before tax Rs m-1-2-82489 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m000528 
Profit after tax Rs m-1-2-82061 
Gross profit margin %-143.6NMNM11.513.4 
Effective tax rate %31.00019.431.2 
Net profit margin %-167.4NMNM14.513.4 
BALAXI PHARMA BALANCE SHEET DATA
Current assets Rs m3231658349 
Current liabilities Rs m4012682 
Net working cap to sales %-342.7NMNM23.558.4 
Current ratio x0.650.812.52.24.2 
Inventory Days Days25,005NMNM97 
Debtors Days Days15NMNM147238 
Net fixed assets Rs m3300311 
Share capital Rs m30303030100 
"Free" reserves Rs m1-7-155177 
Net worth Rs m31231635277 
Long term debt Rs m00000 
Total assets Rs m35241761360 
Interest coverage x-1.5-3.2NM1,221.0185.9 
Debt to equity ratio x00000 
Sales to assets ratio x0002.21.3 
Return on assets %-0.9-5.6-45.632.217.1 
Return on equity %-2.6-7.5-49.555.822.0 
Return on capital %-2.2-5.7-49.569.332.2 
Exports to sales %0NMNM00 
Imports to sales %0NMNM00 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m000136456 
Fx outflow Rs m000010 
Net fx Rs m000136447 
BALAXI PHARMA CASH FLOW
From Operations Rs m 0 -1 -7 -15 -141 
From Investments Rs m 1 27 0 0 -2 
From Financial Activity Rs m -1 -2 0 0 181 
Net Cashflow Rs m 0 23 -7 -15 39 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 72.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 19.5%
FIIs 19.5%
ADR/GDR 0.0%
Free float 27.1%
Shareholders 2,636
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Plot No.409 3rd Floor, Maps Towers Jubilee Hills, Road No:81, Hyderabad - 500096
E-MAIL info@balaxipharma.in WEB www.balaxipharma.in
TEL 040 23555300 FAX
SECTOR TRADING GROUP Private sector
TR AGENT SKDC Consultants Ltd, Kanapathy Towers 3rd Floor, Ganapathy
YEAR OF INC: 1942 NSE CODE: 911309 FV (Rs): 10 DIV YIELD (%): -

More Trading Company Fact Sheets:   GUJ.TERC LAB  ERIS LIFESCIENCES  ARTEMIS MEDICARE SERVICES  KERALA AYURV  DR. REDDYS LAB  

Compare BALAXI PHARMA With:   GUJ.TERC LAB  ERIS LIFESCIENCES  ARTEMIS MEDICARE SERVICES  KERALA AYURV  DR. REDDYS LAB  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BALAXI PHARMA

  • Track your investment in BALAXI PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BALAXI PHARMA

BALAXI PHARMA - LONGVIEW TEA COMPARISON

COMPARE BALAXI PHARMA WITH

MARKET STATS